Freenome Inc(PCSC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.07 | Insider Own | 51.28% | Shs Outstand | 8.2M | Perf Week | - |
| Market Cap | 0.10B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 5.0M | Perf Month | 9.83% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 15.36% | Perf Quarter | 6.03% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 6.06 | Perf Half Y | -14.03% |
| Sales | 0.00B | P/B | 1.57 | EPS next 5Y | - | ROA | -0.86% | Short Interest | 0.77M | Perf YTD | -8.29% |
| Book/sh | 7.64 | P/C | 234.16 | EPS past 3/5Y | - | ROE | -0.92% | 52W High | -17.42% ($14.47) | Perf Year | 11.68% |
| Cash/sh | 0.05 | P/FCF | - | Sales past 3/5Y | - | ROIC | -0.97% | 52W Low | 20.1% ($9.95) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -123.69% | Gross Margin | - | Volatility(W/M) | 4.68% 3.71% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.2 | EPS Q/Q | -116.28% | Profit Margin | - | RSI (14) | 64.68 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.2 | Sales Q/Q | - | SMA20 | 6.47% ($11.22) | Beta | 0.29 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 6.64% ($11.21) | Rel Volume | 0 | Prev Close | $11.95 |
| Employees | 3 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 2.29% ($11.68) | Avg Volume(3M) | 0.13M | Price | $11.95 |
| IPO | 2024/6/12 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
Company
PCSC is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Perceptive Capital Solutions (PCSC) is a special purpose acquisition company (SPAC) established with the goal of acquiring a life science or medical technology company. Backed by a prominent life sciences-focused investment firm as sponsor, it deposits the proceeds from its IPO into a trust account while seeking a promising healthcare company in North America or Europe as a merger target.
Over the past 1 year, roughly in the middle
17% below its 1-year high.
PCSC has weak earning power
Review management risk carefully before investing
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 51.3%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $103M.
PCSC $103M PER -
LION $3B PER -
BBCQ $2B PER -
CCXI $686M PER -
FAQ
What kind of company is PCSC?
PCSC belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of PCSC?
The market cap of PCSC is approximately $103M, ranking 4,525 within its sector.
What is the 52-week high and low for PCSC?
PCSC has recorded a 52-week high of $14.47 and a low of $9.95.
